                </a></li></ul></div><p><strong>Figure 1.  <span>DUC18 CTL mediate regression of CMS5 tumors.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>3×10<sup>6</sup> CMS5 tumor cells were injected s.c. and were allowed to grow for 8 days prior to transfer of 30×10<sup>6</sup> in vitro activated DUC18 T cells. This transfer protocol was repeated for all subsequent experiments. A) Tumor sizes for 6 DUC18 T cell<sup>+</sup> recipient and 4 control mice are shown. Data are representative of 3 experiments. B) Mean tumor sizes +/− SEM for 30 DUC18 T cell<sup>+</sup> recipient mice.</p>
<span>THISISTHEEND
